India records 55,839 new infections, 702 deaths

0
The number of coronavirus infections reported in a span of 24 hours remained below 60,000 for the fourth consecutive day on Thursday as India's caseload went past 77 lakh, while recoveries have crossed 68 lakh, according to data updated by the Union Health Ministry The COVID-19 caseload mounted to?77,06,946 with?55,839 new infections being reported in a day, while the death...

Plasma Therapy May Be Removed From Covid Treatment Guideline

0
Convalescent plasma therapy may be removed from the national guideline on treatment of coronavirus, chief of India's top medical research body ICMR Dr Balram Bhargava said at a Health Ministry briefing today. "We have had discussions it (use of plasma therapy) at the national taskforce-level... more or less we are reaching towards that," ICMR Director General Dr Balram said in...

Russia Receives Renewed Approval For COVID-19 Vaccine Trials In India

0
The Russian Direct Investment Fund (RDIF) and Dr Reddy's Laboratories Ltd have received renewed approval to conduct late-stage clinical trials in India of the Russian COVID-19 vaccine, the sovereign wealth fund said on Saturday. Large-scale trials of the Sputnik V vaccine in India were first announced and then knocked back by Indian regulators, who said the scale of Phase I...

COVID-19 Reinfection Casts Doubt On Virus Immunity: Study

0
Covid-19 patients may experience more severe symptoms the second time they are infected, according to research released Tuesday confirming it is possible to catch the potentially deadly disease more than once. A study published in The Lancet Infectious Diseases journal charts the first confirmed case of Covid-19 reinfection in the United States -- the country worst hit by the pandemic...

Johnson & Johnson Pauses Covid Vaccine Trial As Participant Falls Ill

0
Johnson & Johnson said Monday it had temporarily halted its Covid-19 vaccine trial because one of its participants had become sick. "We have temporarily paused further dosing in all our Covid-19 vaccine candidate clinical trials, including the  Phase 3 ENSEMBLE trial, due to an unexplained illness in a study participant," the company said in a statement. The pause means the online...

Less than 1000 coronavirus deaths recorded for 8 consecutive days in India

0
India's COVID-19 recoveries crossed the 60-lakh mark, while less than 1000 coronavirus deaths have been recorded daily for eight consecutive days, the Union Health Ministry said on Sunday. Active cases of coronavirus are less than nine lakh for the third day in a row. With increasing recoveries, India has sustained its leading global position with the maximum recovered cases. The five top...

COVID-19: Active cases in India fall below 9 lakh after one month

0
India's COVID-19 tally of cases went past 69 lakh with 70,496 infections being reported in a day, while active cases of infection fell below 9 lakh after a month comprising 12.94 per cent of the total caseload, according to the Union Health Ministry data updated on Friday. The total coronavirus cases mounted to 69,06,151. The death toll climbed to 1,06,490...

COVID-19:Less than 10 lakh active cases for 13th consecutive day in country

0
For the 13th day in an "unbroken string", India has maintained its steady trend of clocking less than 10 lakh active cases of COVID-19, the Union Health Ministry said on Sunday. It also said that an average of 11.5 lakh tests for detection of coronavirus infection were done on a daily basis during the past ten days. From merely one in...

India Maintains Top Global Ranking With Maximum COVID-19 Recoveries

0
India continues to occupy the top global position with the maximum number of COVID-19 recoveries and accounts for 21 per cent of the recovered cases worldwide, while its share in the total cases stands at 18.6 per cent, the Union Health Ministry said today. India has also maintained its global position with one of the lowest COVID-19 case fatality rates...

Moderna’s Coronavirus Vaccine Won’t Be Ready Before US Elections: Report

0
US biotech firm Moderna won't seek an emergency use authorization for its coronavirus vaccine before November 25, its CEO told the Financial Times on Wednesday. The news deals a blow to President Donald Trump's hopes of having an injection ready before the election to give his campaign a much-needed boost. Stephane Bancel told the newspaper: "November 25 is the time we...